| Product Code: ETC13280241 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Lung Cancer Therapeutics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Lung Cancer Therapeutics Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Lung Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Lung Cancer Therapeutics Market - Industry Life Cycle |
3.4 Africa Lung Cancer Therapeutics Market - Porter's Five Forces |
3.5 Africa Lung Cancer Therapeutics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Lung Cancer Therapeutics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Africa Lung Cancer Therapeutics Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.8 Africa Lung Cancer Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.9 Africa Lung Cancer Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
4 Africa Lung Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Lung Cancer Therapeutics Market Trends |
6 Africa Lung Cancer Therapeutics Market, 2021 - 2031 |
6.1 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031 |
6.1.3 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Metastatic Lung Cancer, 2021 - 2031 |
6.1.4 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Pulmonary Neuroendocrine Tumors, 2021 - 2031 |
6.1.5 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Mediastinal Tumors, 2020 - 2028 |
6.1.6 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Mesothelioma, 2020 - 2028 |
6.1.7 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Chest Wall Tumors, 2020 - 2028 |
6.2 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Molecule Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Small Molecules, 2021 - 2031 |
6.2.3 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Biologics, 2021 - 2031 |
6.3 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Alkylating Agents, 2021 - 2031 |
6.3.3 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Antimetabolites, 2021 - 2031 |
6.3.4 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By EGFR Inhibitors, 2021 - 2031 |
6.3.5 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Mitotic Inhibitors, 2021 - 2031 |
6.3.6 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Multikinase Inhibitors, 2021 - 2031 |
6.4 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Chemotherapy, 2021 - 2031 |
6.4.3 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Radiation Therapy, 2021 - 2031 |
6.4.4 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Targeted Therapy, 2020 - 2028 |
6.4.5 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Immunotherapy, 2020 - 2028 |
7 Africa Lung Cancer Therapeutics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.1 South Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.2 Egypt Lung Cancer Therapeutics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.3 Nigeria Lung Cancer Therapeutics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.4 Rest of Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3 Africa Lung Cancer Therapeutics Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
7.3.1 South Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Molecule Type, 2021 - 2031 |
7.3.2 Egypt Lung Cancer Therapeutics Market, Revenues & Volume, By Molecule Type, 2021 - 2031 |
7.3.3 Nigeria Lung Cancer Therapeutics Market, Revenues & Volume, By Molecule Type, 2021 - 2031 |
7.3.4 Rest of Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Molecule Type, 2021 - 2031 |
7.4 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.1 South Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.2 Egypt Lung Cancer Therapeutics Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.3 Nigeria Lung Cancer Therapeutics Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.4 Rest of Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.5 Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5.1 South Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5.2 Egypt Lung Cancer Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5.3 Nigeria Lung Cancer Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5.4 Rest of Africa Lung Cancer Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8 Africa Lung Cancer Therapeutics Market Key Performance Indicators |
9 Africa Lung Cancer Therapeutics Market - Export/Import By Countries Assessment |
10 Africa Lung Cancer Therapeutics Market - Opportunity Assessment |
10.1 Africa Lung Cancer Therapeutics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Lung Cancer Therapeutics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.3 Africa Lung Cancer Therapeutics Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
10.4 Africa Lung Cancer Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.5 Africa Lung Cancer Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
11 Africa Lung Cancer Therapeutics Market - Competitive Landscape |
11.1 Africa Lung Cancer Therapeutics Market Revenue Share, By Companies, 2022 |
11.2 Africa Lung Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here